McRae Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.65M Sell
10,439
-1,234
-11% -$288K 0.52% 40
2026
Q1
$2.85M Buy
11,673
+10
+0.1% +$2.33K 0.59% 38
2025
Q4
$2.41M Sell
11,663
-925
-7% -$183K 0.49% 32
2025
Q3
$2.33M Buy
12,588
+40
+0.3% +$6.85K 0.46% 33
2025
Q2
$1.92M Sell
12,548
-515
-4% -$79.2K 0.39% 35
2025
Q1
$2.17M Sell
13,063
-23
-0.2% -$3.6K 0.46% 35
2024
Q4
$1.89M Sell
13,086
-1,050
-7% -$163K 0.37% 35
2024
Q3
$2.29M Buy
14,136
+23
+0.2% +$3.67K 0.45% 31
2024
Q2
$2.06M Sell
14,113
-601
-4% -$89.4K 0.47% 29
2024
Q1
$2.33M Sell
14,714
-3,644
-20% -$580K 0.51% 30
2023
Q4
$2.88M Sell
18,358
-721
-4% -$111K 0.72% 26
2023
Q3
$2.97M Sell
19,079
-1,524
-7% -$251K 0.88% 26
2023
Q2
$3.41M Sell
20,603
-373
-2% -$60.2K 0.97% 27
2023
Q1
$3.25M Sell
20,976
-46
-0.2% -$7.43K 0.94% 28
2022
Q4
$3.71M Buy
21,022
+138
+0.7% +$23.8K 1.09% 27
2022
Q3
$3.41M Sell
20,884
-956
-4% -$162K 1.04% 30
2022
Q2
$3.88M Buy
21,840
+509
+2% +$90.7K 1.05% 32
2022
Q1
$3.78M Buy
21,331
+744
+4% +$127K 0.85% 34
2021
Q4
$3.52M Sell
20,587
-97
-0.5% -$15.9K 0.73% 33
2021
Q3
$3.34M Sell
20,684
-162
-0.8% -$27.6K 0.74% 33
2021
Q2
$3.43M Sell
20,846
-1,181
-5% -$196K 0.79% 32
2021
Q1
$3.62M Buy
22,027
+281
+1% +$45.5K 0.9% 30
2020
Q4
$3.42M Buy
21,746
+355
+2% +$52.4K 0.98% 31
2020
Q3
$3.19M Buy
21,391
+1,993
+10% +$295K 1.07% 29
2020
Q2
$2.73M Buy
19,398
+45
+0.2% +$6.56K 1.02% 30
2020
Q1
$2.54M Sell
19,353
-222
-1% -$31.5K 1.24% 27
2019
Q4
$2.85M Buy
19,575
+3
+0% +$407 1.05% 30
2019
Q3
$2.53M Sell
19,572
-72
-0.4% -$9.49K 0.99% 31
2019
Q2
$2.74M Buy
19,644
+524
+3% +$72.5K 1.09% 28
2019
Q1
$2.67M Sell
19,120
-1,452
-7% -$194K 1.11% 26
2018
Q4
$2.65M Sell
20,572
-1,247
-6% -$174K 1.37% 23
2018
Q3
$3.02M Sell
21,819
-5,416
-20% -$720K 1.28% 25
2018
Q2
$3.31M Buy
27,235
+4,077
+18% +$509K 1.38% 26
2018
Q1
$2.97M Sell
23,158
-4,082
-15% -$552K 1.34% 25
2017
Q4
$3.81M Sell
27,240
-544
-2% -$75.8K 1.61% 23
2017
Q3
$3.61M Sell
27,784
-1,093
-4% -$145K 1.55% 24
2017
Q2
$3.82M Buy
28,877
+584
+2% +$74.5K 1.55% 25
2017
Q1
$3.52M Sell
28,293
-698
-2% -$83.4K 1.45% 25
2016
Q4
$3.34M Sell
28,991
-727
-2% -$84K 1.47% 25
2016
Q3
$3.51M Sell
29,718
-1,168
-4% -$142K 1.6% 26
2016
Q2
$3.75M Buy
30,886
+1,073
+4% +$122K 1.73% 22
2016
Q1
$3.23M Buy
29,813
+1,458
+5% +$151K 1.44% 26
2015
Q4
$2.91M Buy
28,355
+200
+0.7% +$20.1K 1.4% 26
2015
Q3
$2.63M Sell
28,155
-3,400
-11% -$329K 1.34% 27
2015
Q2
$3.08M Sell
31,555
-1,441
-4% -$144K 1.43% 27
2015
Q1
$3.32M Sell
32,996
-1,200
-4% -$122K 1.53% 27
2014
Q4
$3.58M Buy
34,196
+1,516
+5% +$160K 1.65% 25
2014
Q3
$3.48M Buy
32,680
+100
+0.3% +$10.4K 1.69% 24
2014
Q2
$3.41M Buy
32,580
+50
+0.2% +$5.05K 1.64% 25
2014
Q1
$3.19M Sell
32,530
-500
-2% -$46.4K 1.61% 26
2013
Q4
$3.02M Sell
33,030
-207
-0.6% -$19.1K 1.55% 26
2013
Q3
$2.88M Sell
33,237
-950
-3% -$85.2K 1.59% 25
2013
Q2
$2.94M Buy
+34,187
New +$2.9M 1.71% 25

Other funds holding JNJ

McRae Capital Management's JNJ Position: Q2 2026 in Review

McRae Capital Management reduced its Johnson & Johnson (JNJ) stake by 11% in Q2 2026, selling an estimated $288K and leaving 10,439 shares worth $2.65M. The position accounts for 0.52% of the portfolio, ranked #40.

McRae Capital Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.88M in Q2 2022. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • McRae Capital Management held 10,439 shares of Johnson & Johnson worth $2.65M as of Q2 2026.
  • McRae Capital Management sold 1,234 Johnson & Johnson shares in Q2 2026, an estimated $288K.
  • Johnson & Johnson made up 0.52% of McRae Capital Management's portfolio in Q2 2026, its #40 holding.
  • McRae Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • McRae Capital Management's Johnson & Johnson position peaked at $3.88M in Q2 2022.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on McRae Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.